SPOTLIGHT -
Slideshow
Author(s):
Three new studies on genetic risk factors and lifestyle; the transition from cognitive health to Alzheimer disease; and metabolic syndrome in depressed older adults.
AXS-05 Demonstrates Efficacy and Manageable Adverse Effects in Major Depressive Disorder Treatment
Blue Light Blockers: A Behavior Therapy for Mania
CYB003 for the Adjunctive Treatment of Major Depressive Disorder
Blue Light, Depression, and Bipolar Disorder
Positive Results in Phase 2b Trial of Psychedelic Agent GH001 for Treatment-Resistant Depression
The Impact of Selective Serotonin Reuptake Inhibitors on Bleeding Risk: A Comprehensive Review